Literature DB >> 24577922

Bone Marrow Stromal Cell (BMSC) and skeletal aging: role of telomerase enzyme.

Hamid Saeed1, Mehwish Iqtedar2.   

Abstract

Telomere shortening and telomerase deficiency have been linked with several age related degenerative diseases. Moreover, degenerative changes in various tissues/organs have been attributed to derangement of stem cell functions causing regenerative tragedy. Bone marrow stromal cells (BMSCs) are considered the ideal candidates for regenerative approaches owing to their beneficial effects in numerous clinical applications. Thus, the effect of telomerase deficiency in perpetrating age related changes in BMSC functions during in vitro culture; their morphology, proliferation and differentiation, that can be extrapolated and reasoned for skeletal aging is conversed in this review. Besides, information regarding pertinent molecular and biochemical markers that can be employed to examine the earliest events, during the course of BMSC aging, is also provided. Additionally, impact of telomerase deficiency in enacting skeletal aging phenotype and its associated microenvironment is also discussed. In the end, further studies, using tissue specific models of telomerase deficiency, are recommended as a future research strategy to advance our understanding of tissue specific telomerase regulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577922

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  5 in total

1.  Transplantation of Hypoxic-Preconditioned Bone Mesenchymal Stem Cells Retards Intervertebral Disc Degeneration via Enhancing Implanted Cell Survival and Migration in Rats.

Authors:  Weiheng Wang; Yang Wang; Guoying Deng; Jun Ma; Xiaodong Huang; Jiangming Yu; Yanhai Xi; Xiaojian Ye
Journal:  Stem Cells Int       Date:  2018-02-14       Impact factor: 5.443

2.  Application of Mesoporous Silica Nanoparticle-Chitosan-Loaded BMP-2 in the Repair of Bone Defect in Chronic Osteomyelitis.

Authors:  Min Yi; Yu Nie; Chengyun Zhang; Bin Shen
Journal:  J Immunol Res       Date:  2022-07-31       Impact factor: 4.493

3.  Cefazolin/BMP-2-Loaded Mesoporous Silica Nanoparticles for the Repair of Open Fractures with Bone Defects.

Authors:  Mingkui Shen; Lulu Wang; Li Feng; Chuangye Xu; Yi Gao; Sijing Li; Yulan Wu; Guoxian Pei
Journal:  Oxid Med Cell Longev       Date:  2022-09-20       Impact factor: 7.310

4.  In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects.

Authors:  Tongmeng Jiang; Guojie Xu; Qiuyan Wang; Lihui Yang; Li Zheng; Jinmin Zhao; Xingdong Zhang
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

5.  Hypoxic preconditioned bone mesenchymal stem cells ameliorate spinal cord injury in rats via improved survival and migration.

Authors:  Weiheng Wang; Xiaodong Huang; Wenbo Lin; Yuanyuan Qiu; Yunfei He; Jiangming Yu; Yanhai Xi; Xiaojian Ye
Journal:  Int J Mol Med       Date:  2018-08-07       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.